J&J | Beneficio Operativo

Operating Profit Cambio Fecha
AbbVie USD 3.2B 914M 2023-12
Amgen USD 1.27B 819M 2023-12
AstraZeneca USD 1.95B 502M 2023-09
Baxter International USD 299M 350M 2023-12
Bayer EUR -3594000000 2.64B 2023-09
Becton, Dickinson and Co. USD 439M 90M 2023-12
Cooper Companies USD 135.7M 15.9M 2023-09
Eli Lilly USD 2.39B 1.94B 2023-12
Gilead Sciences USD 1.61B 1.01B 2023-12
GlaxoSmithKline GBP 1.95B 192M 2023-09
Globus Medical USD 10.12M 9.72M 2023-12
Hologic USD 198.2M 65.7M 2023-12
Insulet USD 106.4M 51.6M 2023-12
Integra LifeSciences USD 35.93M 9.46M 2023-12
Merit Medical Systems USD 35.14M 6.32M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
Regeneron Pharmaceuticals USD 972.9M 138.1M 2023-12
Roche Holding CHF 9.76B 3.84B 2023-06
Stryker USD 1.26B 326M 2023-12
Tandem Diabetes Care USD -35060000 3.51M 2023-12
Teva Pharmaceutical Industries USD 355M 1B 2023-09
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09
Zimmer Biomet Holdings USD 354.2M 87.6M 2023-12
Zoetis USD 650M 67M 2023-12



J&J Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2024.